Detalhe da pesquisa
1.
Role of the Intestine and Its Gut Microbiota in Metabolic Syndrome and Obesity.
Am J Gastroenterol
; 119(6): 1038-1046, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38372280
2.
Re-Cellularization via Electroporation Therapy of the duodenum combined with GPL-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes; 12 months results of a first-in-human study.
Gastrointest Endosc
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692517
3.
Insulin sensitivity and beta cell function after Duodenal Mucosal Resurfacing (DMR): An Open-Label, Mechanistic, Pilot Study.
Gastrointest Endosc
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280531
4.
Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes.
Am J Physiol Endocrinol Metab
; 322(2): E132-E140, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957857
5.
Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study.
Gastrointest Endosc
; 94(1): 111-120.e3, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33359437
6.
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study.
Gut
; 69(2): 295-303, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331994
7.
Response.
Gastrointest Endosc
; 96(5): 875-876, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270709
8.
Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
Gut
; 70(11): 2196-2204, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34497147
9.
The Duodenum harbors a Broad Untapped Therapeutic Potential.
Gastroenterology
; 154(4): 773-777, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29428335
10.
A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study.
Front Clin Diabetes Healthc
; 3: 856661, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992788
11.
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study).
Diabetes Res Clin Pract
; 184: 109194, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032562
12.
Duodenal mucosal resurfacing: Multicenter experience implementing a minimally invasive endoscopic procedure for treatment of type 2 diabetes mellitus.
Endosc Int Open
; 8(11): E1683-E1689, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140025
13.
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results.
JHEP Rep
; 1(6): 429-437, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039394
14.
Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites.
Endocr Connect
; 7(5): 673-680, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669802